TP53INP1 and neoplasm: In addition, miR-155 has also been identified as an oncomiR in various types of human tumors, which inhibits the activity of tumor suppressor targets such as TP53INP1 or the von Hippel–Lindau (VHL) tumor suppressor protein [59,60].